Richard K.
- Country
- Czechia
- Department
- Nemocnice Český Krumlov, a.s.
Research Overview
- J2A-MC-GZGQ: A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once-Daily Oral LY3502970 Compared With Placebo in Adult Participants With Obesity or Overweight and Type 2 Diabetes (ATTAIN-2)
- Efficacy and Safety of Efepoetin Alfa Versus Darbepoetin Alfa in Anemia Management for Chronic Kidney Disease Patients on Dialysis: A Phase III Randomized Study
- Efficacy and Safety of Efepoetin Alfa Versus Darbepoetin Alfa in Anemia Management for Chronic Kidney Disease Patients on Dialysis
Data & Insights
Has run more than one trial at 93 of 616 partner sites.
Specializations
Metabolic Disorders
This investigator specializes in the treatment of Type 2 Diabetes and its relationship with obesity and overweight conditions. Their research encompasses comprehensive metabolic health management approaches.
- Weight Management in Diabetes
- Metabolic Control
- Obesity Treatment
Their work focuses on innovative therapeutic approaches for patients with combined metabolic conditions.
Cardiovascular Health
The investigator studies the intersection of cardiovascular diseases with metabolic disorders, particularly focusing on patients at increased cardiovascular risk with concurrent diabetes and obesity.
- Cardiovascular Risk Management
- Preventive Cardiology
- Metabolic-Cardiovascular Interactions
Their research addresses the complex relationship between metabolic disorders and cardiovascular outcomes.
Nephrology
The investigator has expertise in treating chronic kidney disease and associated conditions, with particular focus on renal anemia in dialysis patients.
- Anemia Management in CKD
- Dialysis Care
- Renal Complications
Their work emphasizes optimizing treatment outcomes for patients with kidney disease and related complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.